Vol 24, No 3 (2020)

Date published: 2020-09-29

Table of Contents

open access

Position paper

Treatment of overweight and obesity during and after a pandemic. Let’s not wait for the development of complications — new guidelines for doctors

Magdalena Olszanecka-Glinianowicz, Dominika Dudek, Krzysztof J. Filipiak, Marek Krzystanek, Leszek Markuszewski, Marek Ruchała, Elżbieta Tomiak

Guidelines / Expert consensus

Arterial Hypertension 2020;24(3):93-105.
ORIGINAL PAPERS

Severity of SARS-COV-2 infection and angiotensin converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

Teodoro J. Oscanoa, Xavier Vidal, Alfonso Carvajal, José Amado, Roman Romero-Ortuno

Original paper

Arterial Hypertension 2020;24(3):106-114.

Lack of association between angiotensin-converting enzyme (ACE) genotype and essential hypertension in Peruvian older people

Teodoro J. Oscanoa, Edwin C. Cieza, Frank A. Lizaraso-Soto, María L. Guevara, Ricardo M. Fujita, Roman Romero-Ortuno

Original paper

Arterial Hypertension 2020;24(3):115-119.

Serum amphiregulin and cerebellin 1 levels in primary hypertension patients

Özlem Güler, Hakan Hakkoymaz, Sedat Köroğlu, Muhammed Seyithanoğlu, Hakan Güneş

Original paper

Arterial Hypertension 2020;24(3):120-127.

Objective measurement of physical activity in a random sample of Saint-Petersburg inhabitants

Alexander Orlov, Oxana Rotar, Matthaeus Vigl, Alexandra Konradi, Heiner Boeing

Original paper

Arterial Hypertension 2020;24(3):135-141.



Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl